These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16948218)

  • 1. [Etiology of multiple sclerosis].
    Laplaud DA; Confavreux C
    Rev Prat; 2006 Jun; 56(12):1306-12. PubMed ID: 16948218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Infection by Epstein-Barr virus and multiple sclerosis].
    Alonso A; Egüés Olazábal N; Ayo Martín O
    Neurologia; 2006 Jun; 21(5):249-55. PubMed ID: 16788867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The destructive alliance: interactions of leukocytes, cerebral endothelial cells, and the immune cascade in pathogenesis of multiple sclerosis.
    Minagar A; Carpenter A; Alexander JS
    Int Rev Neurobiol; 2007; 79():1-11. PubMed ID: 17531835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The multiple sclerosis trait and the development of multiple sclerosis: genetic vulnerability and environmental effect.
    Poser CM
    Clin Neurol Neurosurg; 2006 Mar; 108(3):227-33. PubMed ID: 16406307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sclerosis: a complicated picture of autoimmunity.
    McFarland HF; Martin R
    Nat Immunol; 2007 Sep; 8(9):913-9. PubMed ID: 17712344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Virus and demyelination: why suspect that a virus may be involved in the aetiology of multiple sclerosis?].
    Fernández-Muñoz R; Celma-Serrat M
    Rev Neurol; 2002 Nov 16-30; 35(10):964-72. PubMed ID: 12436401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multiple sclerosis: results and prospects of research].
    Zavalishin IA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(2):161-7. PubMed ID: 7041492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotrophic cross-talk between the nervous and immune systems: relevance for repair strategies in multiple sclerosis?
    Hohlfeld R
    J Neurol Sci; 2008 Feb; 265(1-2):93-6. PubMed ID: 17459415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Etiology of multiple sclerosis].
    Confavreux C; Goudable B; Moreau T
    Rev Prat; 1991 Sep; 41(20):1888-92. PubMed ID: 1925371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunology of multiple sclerosis.
    Sospedra M; Martin R
    Annu Rev Immunol; 2005; 23():683-747. PubMed ID: 15771584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis: immunopathogenesis and controversies in defining the cause.
    Holmøy T; Hestvik AL
    Curr Opin Infect Dis; 2008 Jun; 21(3):271-8. PubMed ID: 18448972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis.
    Hohlfeld R; Kerschensteiner M; Stadelmann C; Lassmann H; Wekerle H
    Neurol Sci; 2006 Mar; 27 Suppl 1():S1-7. PubMed ID: 16708174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation.
    Zozulya AL; Wiendl H
    Hum Immunol; 2008 Nov; 69(11):797-804. PubMed ID: 18723060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sclerosis: etiology and epidemiology.
    Inverso MJ; Dolezal JL; Rath GA; Jung BA
    J Am Optom Assoc; 1979 Feb; 50(2):185-7. PubMed ID: 458098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CD8 T cell in multiple sclerosis: suppressor cell or mediator of neuropathology?
    Johnson AJ; Suidan GL; McDole J; Pirko I
    Int Rev Neurobiol; 2007; 79():73-97. PubMed ID: 17531838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8+ T cells in inflammatory demyelinating disease.
    Weiss HA; Millward JM; Owens T
    J Neuroimmunol; 2007 Nov; 191(1-2):79-85. PubMed ID: 17920696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate immune CD11b+Gr-1+ cells, suppressor cells, affect the immune response during Theiler's virus-induced demyelinating disease.
    Bowen JL; Olson JK
    J Immunol; 2009 Dec; 183(11):6971-80. PubMed ID: 19890055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies.
    Szczuciński A; Losy J
    Acta Neurol Scand; 2007 Mar; 115(3):137-46. PubMed ID: 17295707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunology of multiple sclerosis: disease mechanisms and therapeutic targets.
    Holmøy T
    Minerva Med; 2008 Apr; 99(2):119-40. PubMed ID: 18431322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis.
    Stüve O; Marra CM; Bar-Or A; Niino M; Cravens PD; Cepok S; Frohman EM; Phillips JT; Arendt G; Jerome KR; Cook L; Grand'Maison F; Hemmer B; Monson NL; Racke MK
    Arch Neurol; 2006 Oct; 63(10):1383-7. PubMed ID: 17030653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.